FDA issued a Warning Letter to Hillestad Pharmaceuticals USA, Inc. on 4/17/2013 for a later inspection.
483 Hillestad Pharmaceuticals USA May 2011

483 Hillestad Pharmaceuticals USA May 2011

Justin Boyd FDA$119.00 - Available Now

FDA investigators audited the Hillestad Pharmaceuticals USA - Woodruff, WI, United States facility and issued inspectional observations (via FDA 483) on 12 May 2011.

Product details

  • Category: Foods & Cosmetics
  • Inspection end: 12 May 2011
  • Location: Woodruff, United States
  • FEI: 2917045
Add To Cart